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A case of aortic graft infection with bacille Calmette-Gu~rin (BCG) is described. The graft 
was placed during urgent repair of a ruptured abdominal aortic aneurysm 2 years after 
intravesical dministration of BCG for grade I I  transitional cell carcinoma of the bladder 
with associated carcinoma in situ. At the time of operation, no gross evidence of infection 
was found and pathologic examination of the aortic wall was unremarkable. Aortic graft 
infection with BCG was diagnosed 1 year after placement of the graft. Retrospective 
examination of formalin-fixed, paraffin-embedded aortic wall and thrombus removed at 
the time of graft placement by the polymerase chain reaction technique demonstrated the 
presence of mycobacterial DNA. The patient's condition improved with medical therapy 
during an observation period of 18 months with near total resolution on computed 
tomography scanning. Ultimately (20 months later), an aortoenteric fistula developed that 
required graft removal and axillobifemoral bypass. (J VASC SURG 1995;22:80-4.) 
Bacille Calmette-Gudrin (BCG) is an attenuated 
strain of A/iycobacterium boris that has been used as a 
vaccination against tuberculosis. 1 It has also been 
used as an immunoadjuvant in the treatment of 
several neoplastic diseases 2,3 and particularly in the 
treatment of  superficial bladder cancer, where it is 
applied topically by intravesical instillation. 4 The 
complication rate of  this mode of therapy has been 
low, but pneumonitis and hepatitis (0.7%), systemic 
sepsis (0.4%), distant abscesses, and other complica- 
tions have been reported. 5,6 To our knowledge, only 
two cases of BCG infection after intravesical BCG 
therapy involving major arteries have been reported 
in the English-language literature. 7,8 
We report here a case of an initially unsus- 
pected BCG infection of  a ruptured abdominal aortic 
aneurysm (AAA) and subsequent infection of the 
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implanted aortic graft, associated with intravesical 
administration of BCG. 
CASE REPORT 
An 80-year-old white man was referred for evaluation 
of acute right lower back pain accompanied by weakness 
and pain radiating clown his right lower extremity. He 
reported a 2-month history of malaise and night sweats. 
The patient had been receiving high-dose dexamethasone 
for a presumed iagnosis of spinal cord compression for 2 
days. Two years before admission he underwent transure- 
thral resection of a grade II urothelial carcinoma of the 
bladder. After resection and documentation f carcinoma 
in situ, the patient received seven intravesical instillations of 
BCG (3 × 108 colony-forming units) in 50 ml of normal 
saline solution. After the seventh instillation, the patient 
had development of severe weakness accompanied by fever 
and rigors. A bladder biopsy performed 2 weeks after the 
seventh instillation showed no granulomas or evidence of 
mlTlor.  
On examination the patient was in obvious discomfort. 
His pulse rate was 80 bcats/min, blood pressure was 
120/70 mm Hg, and he was without fever. The chest 
examination result was normal, and abdominal examina- 
tion revealed tenderness in the right lower quadrant. 
Moderate weakness of the right psoas and quadriceps 
muscles was noted. The urinalysis result was normal, 
leukocyte count was 9100/ram 3 (58% bands, 5% lympho- 
cytcs), hemoglobin was 12.8 g/dl, and hematocrit was 
37.4%. Radiographs of the chest and the lumbar spine 
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Fig. 1. CT scan of abdomen demonstrates partially calcified, infrarenal AAA with rupture 
contained within right psoas muscle. 
were normal. Computed tomography (CT) scanning 
demonstrated rupture of an infrarenal AAA contained 
within the right psoas muscle (Fig. 1). The ruptured 
aneurysm was repaired with a woven Dacron bifurcation 
graft anastomosed to the infrarenal aorta and the common 
iliac arteries. No evidence of infection was found, and a 
sample of the aortic wall and luminal thrombus were sent 
for routine histopathologic examination, the result of 
which was reported as unremarkable. The patient had an 
uneventful recovery and was discharged on the ninth 
postoperative day. Five months later the patient had an 
acute myocardial infarction and underwent percutaneous 
transluminal coronary angioplasty, coronary stent place- 
ment, and eventually an emergency coronary artery bypass 
from which he recovered without complication. 
One year after the aortic repair, the patient was 
admitted with a recurrent dull ache in the right lower 
extremity, accompanied by progressive fatigue, weight loss, 
night sweats, fever, and chills, which had developed over a 
period of 2 months. CT scanning demonstrated fluid 
surrounding the aortic graft and extending into the right 
psoas muscle (Fig. 2, A). Indium i l l - labeled leukocyte 
scanning did not show excessive activity in the region of the 
graft. Needle aspiration of the perigraft fluid under CT 
guidance revealed thick, white material that demonstrated 
acid-fast bacilli on smear and ultimately grewA//, bovis strain 
BCG in culture. 
Because there was no gross evidence of infection at the 
time of the original operation, and histopathologic exami- 
nation of the aortic wall failed to reveal evidence of 
mycobacterial infection, the source of this graft infection 
remained uncertain. We therefore retrieved the 1-year-old, 
formalin-fixed, paraffin-embedded aortic wall and luminal 
thrombus, which had been submitted at the original 
operation, and examined them for the presence of myco- 
bacterial DNA, the results of which were positive. 
Treatment with ethambutol, rifampin, and isoniazid 
resulted in resolution of symptoms and a weight gain of 10 
Kg. On repeated CT scans the quantity of fluid around the 
graft decreased but did not disappear (Fig. 2, B). After 20 
months of therapy the patient had development of a 
graft-enteric fistula, and an emergency axillobifemoral 
bypass and graft removal was carried out successfully. 
Streptococcus viridans and Enterococci were cultured from the 
blood and perigraft area, respectively, presumably origi- 
nating from the small bowel after erosion at the graft-right 
iliac anastomosis. 
Analytic methods. DNA was extracted from paraffin- 
embedded, formalin-fixed aortic wall and luminal throm- 
bus 9 and was subjected to 35 cycles of polymerase chain 
reaction (PCR) amplification in a DNA thermocycler 
(Perkin-Elmer Cetus, Norwalk, Conn.). The primers and 
probe were constructed from a repetitive DNA sequence 
of A/lycobacterium tuberculosis, 1° which crossreacts with 
A4. bovis, l~ These primers do not crossreact with human 
vascular tissue. 12 The sequences of the primers 5' to 3' 
were CCTGCGAGCGTAGGCGTCGG and CTCGTC- 
CAGCGCCGCTFCGG. The primers amplified a 123 base 
pair fragment. The sequence of the probe used was 
AGGTGAGGTCTGCTACCCAC. Buffer controls and a 
control sample consisting ofextractedM, tuberculosis DNA 
were processed and included along with the test samples in 
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Fig. 2. CT scan of abdomen 1 year after repair of ruptured AAA (A) and 18 months after 
treatment with antituberculosis therapy (B). Fluid is seen around limbs of graft in 
communication with cavity in right psoas muscle. Fluid was aspirated, smear evealed acid-fast 
bacilli, and culture grew Mycobacterium boris. Arrow points to markedly reduced perigraft fluid 
after antituberculosis treatment. 
the reaction. After amplification, 10 txl of product were 
subjected to liquid-phase hybridization 13with the phos- 
phorus 32-end-labeled probe. The hybridized heterodu- 
plexes were resolved by 6% polyacrylamide gel electro- 
phoresis. 
Analytic results. The radioactively labeled products of 
the PeR were resolved by gel electrophoresis and exposed 
on film (Fig. 3). This demonstrated the presence of 
mycobacterial DNA in the aortic wall and in the luminal 
thrombus at the time of aneurysm rupture. The organism 
grown from the perigraft fluid was M. boris, BCG strain. 
DISCUSSION 
To our knowledge, this is the third case of a 
BCG-infccted AAA reported in the English litera- 
ture. Other reports included a saccular aneurysm 
17 months after intralesional injection of BCG 
into a malignant melanoma, 14 an infected A_AA 
14 months after intravesical instillation of BCG, 
which cuhninated in sepsis and death 7 and bilateral 
femoral aneurysms 2 years after intravesical BCG 
therapy, s 
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Systemic invasion of BCG after intravesical ad- 
ministration is known to occur with higher frequency 
when there is a breach in the integrity of the 
urogenital mucosa, such as after traumatic atheter- 
ization, during severe cystitis, and early after trans- 
urethral surgery, s In this case, the first intravcsicle 
instillation of BCG took place 5 weeks after the 
transurethral esection of the bladder tumor at a time 
when no red blood cells and only 1 to 2 white blood 
cells/high-power field were present in the urine 
sediment. Even though neither active inflammation 
nor bleeding was present, it is postulated that 
infection took place through involvement of the 
retroperitoneal periaortic lymph nodes and involve- 
ment of the aorta by extension similar to the mode of 
spread in tuberculosis,  Indeed, psoas abscesses, 
which may arise by the same mechanism, have also 
been induced by BCG. 16 
During the emergency laparotomy, the findings 
were of a larg e retroperitoneal hematoma nd a 
ruptured AAA. No grossly diseased lymph nodes 
were identified, and the wall of the aneurysm 
appeared appropriate for the circumstances. Al- 
though abscesses may occur, a lack of gross purulence 
with infection with this organism has also been 
observed. 7,~3 The infection was therefore not diag- 
nosed at the original operation. The history of 
malaise and night sweats was not fully appreciated at
the time and received the appropriate attention only 
later. 
DNA amplification by PCR is useful for identi- 
fication of M. tuberculosis and M. bovis and is highly 
specific on sputum specimens and tissue biopsies.~7~9 
Amplification of a target sequence 156110, such as 
was done by us, is particularly advantageous because 
it is found only in the M. tuberculosis complex and is 
repeated there six to 15 times. 12 One exception is 
sarcoidosis where a higher (9%) false-positive rate 
has been reported, 2°a finding that has been contra- 
dicted by others. 21 
Because DNA is a stable molecule, PCR analysis 
is well suited for the analysis of historical specimens. 
Interestingly, in an attempt o shed light on the 
debate regarding tuberculosis n the New World in 
the pre-Columbian era, PCR analysis was performed 
on the remains ofa pre-Columbian Peruvian mummy 
and demonstrated the presence of mycobacterial 
DNA.  22 Detection of mycobacteria byPCR analysis 
in formalin-fixed, paraffin-embedded tissues is also 
possible and has been done with a specificity of 
100%.  23 
Aortic Wall 
Thrombus 
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Fig. 3. Autoradiograph ofPCR products hybridized with 
32p end-labeled specific probe and resolved by 6% poly-
acrylamide gel electrophoresis. Positive signals are seen in 
positive control (lane C), in sample from aortic wall 
(lane A) and faint signal is evident in sample from luminal 
thrombus (lane B). No signal is seen in negative control 
(lane D). 
Treatment of BCG graft infection cannot be 
based on previous experience. In cases of aortic graft 
infection with more common bacteria, medical 
therapy alone is inadequate, and the accepted prin- 
ciples of therapy include removal of the graft, 
extraanatomic or in situ reconstruction, and long- 
term antibiotic therapy. 24,2s In this case, because of 
the low virulence of the infectious agent and its 
documented susceptibility o antimicrobials, aswell 
as the possibility of continued aortic infection, we 
chose to carry out medical therapy. However, the 
infection did not fully resolve after 18 months of 
antituberculosis therapy, and at 20 months the 
patient had development of classic signs of an 
aortoenteric fistula. In spite of the initial marked 
response to medical therapy (Fig. 2, B) and even 
though no mycobacteria grew from cultures taken at 
thc second operation, this patient's course must be 
taken to represent failure of medical therapy. Con- 
sequently, earlier aggressive therapy isrecommended 
in future cases of BCG graft infection. 
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